维普中文期刊产品整合服务
24篇 您的检索式:作者名="ZIESSMAN HA"
    题名 作者 年代 出处 被引量
1Acute eholeeystitis, biliary obstruction, and biliary leakage 显示文摘Ziessman HA 2003Semin Nucl Med2003,33,4:1
2Nuclear medicine hepatobiliary imaging显示文摘Ziessman HA 2010Clin Gastroenterol Hepatol2010,8,2:1
3Sincalide-stimulated cholescintigraphy: a multicenter investigation todetermine optimal infusion methodology and gallbladder ejec-tion fraction normal values 显示文摘Ziessman HA Tulchinsky M Lavely WC 2010J Nucl Med2010,51,2:1
4Hepatobiliary scintigraphy in 2014显示文摘Ziessman HA 2014J Nucl Med Technol2014,42,4:1
5Biphasic solid and liquid gastric emptying in nomal controls and diabetics using continous acquisition in LAO view显示文摘ZIESSMAN HA FAHEY FH COLLEN MJ 1993Dig Dis Sci1993,37,:1
6HepatobiliaryScintigraphy in 2014显示文摘Ziessman HA 2014J Nucl Med2014,55,6:1
7Acute cholecystitis,biliary obstruction,and biliary leakage显示文摘Ziessman HA 2003Semin Nucl Med2003,33,4:1
8Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values显示文摘Ziessman HA Tulchinsky M Lavely WC 2010J Nucl Med2010,51,2:1
9Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel显示文摘DiBaise JK Richmond BK Ziessman HA 2012ClinNucl Med2012,37,1:1
10Hepatic visua-lization of iodine-131whole-body thyroid cancer scans显示文摘Ziessman HA Bahar H Fahey FH 1987J Nucl Med1987,28,10:1
11Protein-losing enteropathy detected by Te-99m-MDP abdominal scintigraphy 显示文摘Uzuner O Ziessman HA 2008Pediatr Radial2008,38,10:1
12Therapy dose calculation in Graves'disease using early ^123I uptake measurements显示文摘Vemulakonda US Atkins FB Ziessman HA 1996Clinical nuclear medicine1996,21,2:1
13Acute cholecystitis, biliary obstruction and biliary leakage显示文摘Ziessman HA 2003Semin Nucl Med2003,33,4:1
14Protein-losing enteropathy detectedby Tc-99m MDP abdominal scintigraphy 显示文摘Uzuner 0 Ziessman HA 2008Pediatr Radiol2008,38,:1
15Nuclear medicine hepatobiliary imaging 显示文摘Ziessman HA 2010Clin Gastroenterol Hepatol2010,8,2:1
16Phase II study of risk-adapted therapy of newly diagnosed,aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning显示文摘Kasamon YL Wahl RL Ziessman HA 0,,:1
17Hepatobiliary Scintigraphy in 2014显示文摘Ziessman HA 2014J Nucl Med Technol2014,42,4:1
18Nuclear medicine hepatobiliay imaging显示文摘Ziessman HA 2010Clin Gastroenterol Hepatol2010,8,2:1
19Nuclear medicine hepatobiliary imaging显示文摘Ziessman HA 2010Clin Gastroenterol Hepatol2010,8,2:1
20Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning显示文摘Kasamon YL Wahl RL Ziessman HA 2009Biol Blood Marrow Transplant2009,15,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费